Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection
- PMID: 24761423
- PMCID: PMC3994626
- DOI: 10.4174/astr.2014.86.3.143
Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection
Abstract
Purpose: Because predicting recurrence intervals and patterns would allow for appropriate therapeutic strategies, we evaluated the clinical and pathological characteristics of early and late recurrences of colorectal cancer.
Methods: Patients who developed recurrence after undergoing curative resection for colorectal cancer stage I-III between January 2000 and May 2006 were identified. Early recurrence was defined as recurrence within 2 years after primary surgery of colorectal cancer. Analyses were performed to compare the clinicopathological characteristics and overall survival rate between the early and late recurrence groups.
Results: One hundred fifty-eight patients experienced early recurrence and 64 had late recurrence. Multivariate analysis revealed that the postoperative elevation of carbohydrate antigen 19-9 (CA 19-9), venous invasion, and N stage correlated with the recurrence interval. The liver was the most common site of early recurrence (40.5%), whereas late recurrence was more common locally (28.1%), or in the lung (32.8%). The 5-year overall survival rates for early and late recurrence were significantly different (34.7% vs. 78.8%; P < 0.001). Survival rates after the surgical resection of recurrent lesions were not different between the two groups.
Conclusion: Early recurrence within 2 years after surgery was associated with poor survival outcomes after colorectal cancer recurrence. An elevated postoperative CA 19-9 level, venous invasion, and advanced N stage were found to be significant risk factors for early recurrence of colorectal cancer.
Keywords: Colorectal neoplasms; Recurrence; Recurrence interval; Risk factors; Survival.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Optimal Surveillance Protocols After Curative Resection in Patients With Stage IV Colorectal Cancer: A Multicenter Retrospective Study.Dis Colon Rectum. 2018 Jan;61(1):51-57. doi: 10.1097/DCR.0000000000000950. Dis Colon Rectum. 2018. PMID: 29215480
-
Comparison of clinicopathological characteristics and prognosis between early and late recurrence after curative surgery for colorectal cancer.Am J Surg. 2014 Jun;207(6):922-30. doi: 10.1016/j.amjsurg.2013.08.035. Epub 2013 Nov 10. Am J Surg. 2014. PMID: 24355407
-
Clinical Significance of Early Recurrence After Curative Resection of Colorectal Cancer.Anticancer Res. 2022 Nov;42(11):5553-5559. doi: 10.21873/anticanres.16061. Anticancer Res. 2022. PMID: 36288894
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Future directions for the early detection of colorectal cancer recurrence.J Cancer. 2014 Mar 16;5(4):272-80. doi: 10.7150/jca.8871. eCollection 2014. J Cancer. 2014. PMID: 24790655 Free PMC article. Review.
Cited by
-
Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis.Eur Radiol. 2024 Jun;34(6):3686-3698. doi: 10.1007/s00330-023-10300-3. Epub 2023 Nov 23. Eur Radiol. 2024. PMID: 37994967
-
A Pilot Study: Changes of Gut Microbiota in Post-surgery Colorectal Cancer Patients.Front Microbiol. 2018 Nov 20;9:2777. doi: 10.3389/fmicb.2018.02777. eCollection 2018. Front Microbiol. 2018. PMID: 30515141 Free PMC article.
-
The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study.World J Surg Oncol. 2021 Oct 13;19(1):297. doi: 10.1186/s12957-021-02406-z. World J Surg Oncol. 2021. PMID: 34645481 Free PMC article.
-
The incidence of cancer recurrence and new cancer following commencement of dialysis.Clin Kidney J. 2022 Jun 2;15(9):1770-1781. doi: 10.1093/ckj/sfac124. eCollection 2022 Sep. Clin Kidney J. 2022. PMID: 36003660 Free PMC article.
-
Normalization of the microbiota in patients after treatment for colonic lesions.Microbiome. 2017 Nov 16;5(1):150. doi: 10.1186/s40168-017-0366-3. Microbiome. 2017. PMID: 29145893 Free PMC article.
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] Lyon (FR): International Agency for Research on Cancer; c2014. [cited 2013 Jan 31]. Available from: http://globocan.iarc.fr.
-
- Ministry of Health and Welfare. The Korea central cancer registry. Annual Report of Cancer Incidence in 2008. Seoul: Ministry for Health and Welfare; 2010.
-
- Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg. 1994;81:7–19. - PubMed
-
- Desch CE, Benson AB, 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23:8512–8519. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources